Given that GATA2 and SMAD4 positively correlated with AR signaling in PCa patient tumors (Fig. 7d and Fig. S7a, b), we next examined whether the GATA2 and SMAD4 direct target gene signature correlates with AR signaling. The gene discussed is SMAD4; the disease is posterior cortical atrophy.